Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Midi Health vs Push Health

Midi Health and Push Health sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Midi Health logo

Midi Health

4.6
★★☆☆☆2.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Midi Health →
VS
Push Health logo

Push Health

5.6
★★★☆☆2.8/5

Best for: semaglutide from $950/month

Visit Push Health →

If you are choosing between Midi Health and Push Health, price alone will not settle it. Push Health leads our six-part score, 5.6 to 4.6.

Midi Health vs Push Health price

Push Health publishes $950 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Push Health lists semaglutide; Midi Health does not name its drug.

On format, Midi Health posts no priced format, while Push Health prices brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.

Where each one treats patients

Midi Health lists 50 states, and Push Health does not publish where it ships.

Pricing

Midi Health

Self-pay initial visittelehealth visit
$250/mo

Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.

Self-pay continued care visittelehealth visit
$150/mo

Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.

Push Health

PreliminaryBrand-name
$950/mo
semaglutide

Ozempic / brand

What each price covers

Neither Midi Health nor Push Health spells out what its price covers, so ask whether the visit, the drug and shipping are all in the monthly figure.

Where each one scores higher

Overall, Push Health scores 5.6 and Midi Health 4.6 out of 10.

Midi Health is stronger on trust & safety (5.0 vs 4.0) and accessibility (10.0 vs 5.0).

Push Health is stronger on value (5.3 vs 3.0), effectiveness (9.0 vs 5.0) and user experience (3.0 vs 2.5).

Support is within half a point.

How we score

Midi Health

4.6/10

Overall

Push Health

5.6/10

Value25%

3.0A
vs
B
5.3

Effectiveness25%

5.0A
vs
B
9.0

User Experience15%

2.5A
vs
B
3.0

Trust & Safety15%

5.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.0

FDA warning letters

Neither Midi Health nor Push Health has an FDA warning letter on record with us.

Features & Coverage

FeatureMidi HealthPush Health
Starting PriceNot published$950/mo
Features5 features5 features
States Available50Not disclosed
Compounded——
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Midi Health

Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.

Read our full Midi Health review →

About Push Health

A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.

Read our full Push Health review →

Pros & Cons

Midi Health

What we like

  • Serves all 50 states
  • We found no FDA warning letters issued to Midi Health
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Push Health

What we like

  • Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
  • We found no FDA warning letters issued to Push Health

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Push Health

Push Health wins this one, 5.6 to 4.6, above all for semaglutide from $950/month. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Midi Health if…

You want coverage in all 50 states, which most sellers will not confirm.

Choose Push Health if…

You want semaglutide from $950/month and an opening price near $950 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

Midi Health vs Push Health: FAQ

Only Push Health publishes a price ($950 a month). Midi Health quotes after sign-up.
No. Midi Health lists no named drug; Push Health lists semaglutide.
Midi Health lists 50 states; Push Health does not publish where it ships. Confirm your state before paying.
Neither says. Ask Midi Health and Push Health for an itemized monthly total.
Midi Health has none. Push Health has none.
No. Neither Midi Health nor Push Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.